Cite
HARVARD Citation
Miyoshi, T. et al. (n.d.). 124P Phase II study of neoadjuvant concurrent chemo-immuno-radiation therapy followed by surgery and adjuvant immunotherapy for resectable stage IIIA-B N2 non-small cell lung cancer: SQUAT trial (WJOG 12119L). Immuno-oncology technology. p. . [Online].